Form 4 for CTMX CytomX Therapeutics, Inc.
Accepted 2026-03-19 00:00:00 ET · period of report 2026-03-17 · accession 0001610717-26-000124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-03-19 | 2026-03-17 | CTMX | McCarthy Sean A. | CEO, Dir | S - Sale | $6.42 | -119.0K | 1.08M | -10% | -$763.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-17 | S | D | 118,969 | $6.42 | 1,078,922 | D | — | — | (F2) Includes 457,500 RSUs. |